Conatus sets IPO range

Conatus Pharmaceuticals Inc. (San Diego, Calif.) amended its IPO and new plans to sell 5 million shares at $10-$12. At the $11 midpoint, Conatus would raise $55 million and be valued at $160.3 million. Stifel Nicolaus Weisel; Piper Jaffray; JMP Securities; and SunTrust are underwriters. Last month, Conatus proposed to raise up to $69 million in the offering (see BioCentury, Extra, June 14). ...